Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Gastroenterology|December 6, 2014
Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTKChristine Bernsmeier, Oltin T Pop, Arjuna Singanayagam, et al.
Imeta|July 23, 2026
Integrative host-microbiome modeling uncovers the implication of oral-gut translocation in advanced cirrhosisYi Jin, Frederick Clasen, Fernando Garcia-Guevara, et al.
Alimentary Pharmacology & Therapeutics|March 23, 2026
Disordered Bile Acid Metabolism in Alcohol-Related HepatitisLuke D Tyson, Stephen Atkinson, Benjamin H Mullish, et al.
Journal of Hepatology|September 27, 2021
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trialVishal C Patel, Sunjae Lee, Mark J W McPhail, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 2, 2023
AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate CellsOltin-Tiberiu Pop, Anne Geng, Emilio Flint, et al.
Gut|April 29, 2017
MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failureEvangelos Triantafyllou, Oltin T Pop, Lucia A Possamai, et al.
Hepatology Communications|October 23, 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplantGautam Mehta, Antonio Riva, Maria Pilar Ballester, et al.
Pageof 6